Role of Capecitabine in Treating Metastatic Colorectal Cancer in Chinese Patients

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s38843
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Metastatic Colorectal Cancer: Therapeutic Options for Treating Refractory Disease

Current Oncology
Oncology
2019English

Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Colorectal Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
2010English

Reply: The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2007English

Metastatic Breast Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy